Patents by Inventor Meredith Leong

Meredith Leong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and Methods for Treatment of Ocular Disease Associated with Angiogenesis
    Publication number: 20240131195
    Abstract: The present disclosure provides compositions and methods for the treatment of ocular diseases associated with angiogenesis, particularly wet age-related macular degeneration.
    Type: Application
    Filed: October 5, 2023
    Publication date: April 25, 2024
    Applicant: 4D MOLECULAR THERAPEUTICS INC.
    Inventors: Christian BURNS, Melissa CALTON, Meredith LEONG, Paul SZYMANSKI
  • Methods and compositions using listeria for adjuvant treatment of cancer
    Patent number: 9161974
    Abstract: Provided herein are prime-boost regimens and materials used therein. The prime-boost regimens enhance the immune response to a target antigen. The vaccines used for boost are comprised of recombinant attenuated metabolically active Listeria that encodes an expressible antigen that is cross-reactive with the target antigen. In some examples, the immune response is a cellular immune response.
    Type: Grant
    Filed: May 23, 2011
    Date of Patent: October 20, 2015
    Assignee: ADURO BIOTECH, INC.
    Inventors: Thomas W. Dubensky, Dirk G. Brockstedt, Meredith Leong, Keith S. Bahjat
  • Methods and compositions using for enhancing immunogenicity by prime boost
    Patent number: 8926993
    Abstract: Provided herein are prime-boost regimens and materials used therein. The prime-boost regimens enhance the immune response to a target antigen. The vaccines used for boost are comprised of recombinant attenuated metabolically active Listeria that encodes an expressible antigen that is cross-reactive with the target antigen. In some examples, the immune response is a cellular immune response.
    Type: Grant
    Filed: July 17, 2007
    Date of Patent: January 6, 2015
    Assignee: Aduro Biotech
    Inventors: Thomas W. Dubensky, Jr., Dirk G. Brockstedt, Meredith Leong, Keith S. Bahjat
  • METHODS AND COMPOSITIONS USING LISTERIA FOR ADJUVANT TREATMENT OF CANCER
    Publication number: 20130315950
    Abstract: Provided herein are prime-boost regimens and materials used therein. The prime-boost regimens enhance the immune response to a target antigen. The vaccines used for boost are comprised of recombinant attenuated metabolically active Listeria that encodes an expressible antigen that is cross-reactive with the target antigen. In some examples, the immune response is a cellular immune response.
    Type: Application
    Filed: May 23, 2011
    Publication date: November 28, 2013
    Applicant: ADURO BIOTECH
    Inventors: Thomas W. Dubensky, Dirk G. Brockstedt, Meredith Leong, Keith S. Bahjat
  • METHODS AND COMPOSITIONS USING LISTERIA FOR ENHANCING IMMUNOGENICITY BY PRIME BOOST
    Publication number: 20100233212
    Abstract: Provided herein are prime-boost regimens and materials used therein. The prime-boost regimens enhance the immune response to a target antigen. The vaccines used for boost are comprised of recombinant attenuated metabolically active Listeria that encodes an expressible antigen that is cross-reactive with the target antigen. In some examples, the immune response is a cellular immune response.
    Type: Application
    Filed: July 17, 2007
    Publication date: September 16, 2010
    Applicant: ANZA THERAPEUTICS, INC.
    Inventors: Thomas W. Dubensky, JR., Dirk G. Brockstedt, Meredith Leong, Keith S. Bahjat